Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CONMED Corporation - Common Stock (NY: CNMD )

49.83 +0.12 (+0.24%)
Streaming Delayed Price Updated: 11:54 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CONMED Corporation - Common Stock

< Previous 1 2 3 Next >
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Over the last six months, CONMED shares have sunk to $51.84, producing a disappointing 19.7% loss - worse than the S&P 500’s 7.3% drop. This was partly driven by its softer quarterly results and may... 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Breaking Down Conmed: 4 Analysts Share Their Views
Via Benzinga
These Analysts Slash Their Forecasts On Conmed After Q4 Results
Via Benzinga
Conmed Q4 Earnings Assessment
Via Benzinga
Insights into Conmed Q4 Earnings
Via Benzinga
CONMED CORP (NYSE:CNMD) appears to be flying under the radar despite its strong fundamentals.
CONMED CORP has caught the attention as a great value stock. NYSE:CNMD excels in profitability, solvency, and liquidity, all while being very reasonably priced. 
Via Chartmill
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Earnings Scheduled For February 5, 2025
Via Benzinga
Assessing Conmed: Insights From 6 Financial Analysts
Via Benzinga
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue... 
Via StockStory
Peeling Back The Layers: Exploring Conmed Through Analyst Insights
Via Benzinga
Analyst Scoreboard: 5 Ratings For Conmed
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Conmed
Via Benzinga
Top 3 Health Care Stocks That May Dip This Month
Via Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Misses Revenue for Q2 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains. 
Via InvestorPlace
$1M Bet On Skyworks Solutions? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Beats Revenue for Q1 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Retirement Stocks to Buy at a 52-Week Low in March
Investing in these retirement stocks to buy at one-year lows presents a prime opportunity for long-term gains. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Recap: Conmed Q4 Earnings
Via Benzinga
These Analysts Revise Their Forecasts On CONMED After Q4 Results
CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday. 
Via Benzinga
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.